Chicago Ridge, IL, United States
Chicago Ridge, IL, United States

Time filter

Source Type

— This report studies the global Cancer Stem Cells (CSCs) market, analyzes and researches the Cancer Stem Cells (CSCs) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Janssen Qiagen Advanced Cell Diagnostics ApoCell Biofluidica Clearbridge Biomedics CytoTrack Celsee Fluxion Gilupi Cynvenio On-chip YZY Bio BioView Creatv MicroTech Fluidigm Ikonisys AdnaGen IVDiagnostics Miltenyi Biotec Aviva Biosciences Corporation ScreenCell Silicon Biosystems Market segment by Type, Cancer Stem Cells (CSCs) can be split into CellSearch Others Market segment by Application, Cancer Stem Cells (CSCs) can be split into Breast Cancer Diagnosis and Treatment Prostate Cancer Diagnosis and Treatment Colorectal Cancer Diagnosis and Treatment Lung Cancer Diagnosis and Treatment Other Cancers Diagnosis and Treatment Some Points from Table of Content: Chapter One: Industry Overview of Cancer Stem Cells (CSCs) 1.1 Cancer Stem Cells (CSCs) Market Overview 1.1.1 Cancer Stem Cells (CSCs) Product Scope 1.1.2 Market Status and Outlook 1.2 Global Cancer Stem Cells (CSCs) Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 Cancer Stem Cells (CSCs) Market by Type 1.3.1 CellSearch 1.3.2 Others 1.4 Cancer Stem Cells (CSCs) Market by End Users/Application 1.4.1 Breast Cancer Diagnosis and Treatment 1.4.2 Prostate Cancer Diagnosis and Treatment 1.4.3 Colorectal Cancer Diagnosis and Treatment 1.4.4 Lung Cancer Diagnosis and Treatment 1.4.5 Other Cancers Diagnosis and Treatment Chapter Two: Global Cancer Stem Cells (CSCs) Competition Analysis by Players 2.1 Cancer Stem Cells (CSCs) Market Size (Value) by Players (2016 and 2017) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter Three: Company (Top Players) Profiles 3.1 Janssen 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.1.5 Recent Developments 3.2 Qiagen 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.2.5 Recent Developments 3.3 Advanced Cell Diagnostics 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.3.5 Recent Developments 3.4 ApoCell 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.4.5 Recent Developments 3.5 Biofluidica 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.5.5 Recent Developments 3.6 Clearbridge Biomedics 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.6.5 Recent Developments 3.7 CytoTrack 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.7.5 Recent Developments 3.8 Celsee 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.8.5 Recent Developments 3.9 Fluxion 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.9.5 Recent Developments 3.10 Gilupi 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Cancer Stem Cells (CSCs) Revenue (Value) (2012-2017) 3.10.5 Recent Developments 3.11 Cynvenio 3.12 On-chip 3.13 YZY Bio 3.14 BioView 3.15 Creatv MicroTech 3.16 Fluidigm 3.17 Ikonisys 3.18 AdnaGen 3.19 IVDiagnostics 3.20 Miltenyi Biotec 3.21 Aviva Biosciences Corporation 3.22 ScreenCell 3.23 Silicon Biosystems The Report Contains: 114 Pages. Make an enquire of this report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/288983 . For more information, please visit http://www.orbisresearch.com/reports/index/global-cancer-stem-cells-cscs-market-size-status-and-forecast-2022


A simple and accurate method for characterizing biomarkers in a biological sample using multiple rounds of fluorescent staining is described. The method involves the steps of quenching underrivatizing, amine stripping and regaining (QUAS-R) of cells, tissue or any biological sample.


A microfilter having a hydrophilic surface and suited for size-based capture and analysis of cells, such as circulating cancer cells, from whole blood and other human fluids is disclosed. The filter material is photo-definable, allowing the formation of precision pores by UV lithography. Exemplary embodiments provide a device that combines a microfilter with 3D nanotopography in culture scaffolds that mimic the 3D in vivo environment to better facilitate growth of captured cells.


Patent
Creatv MicroTech Inc. | Date: 2010-05-04

A method of detecting target cells and pathogens in a test sample concentrates to target cells in solution by filtering or capturing the target cells on a solid support. The target cells are tagged with a fluorescent dye and dispersed in a solution or suspension. The resulting solution or suspension are introduced to a fluorometer to specifically identify and quantitate the target cells. The target cells can be lysed or whole when introduced to the fluorometer.


A new sensitive cell biomarker of solid tumors is identified in blood. This biomarker can be used to determine presence of carcinomas, rapid determination of treatment response, early detection of cancer, early detection of cancer recurrence, and may be used to determine therapy.


A microfilter comprising a polymer layer formed from epoxy-based photo-definable dry film, and a plurality of apertures each extending through the polymer layer. A microfilter comprising two or more polymer layers formed from epoxy-based photo-definable dry film, and a plurality of apertures or open areas each extending through the polymer layer. A method of forming a microfilter is also disclosed. The method includes providing a first layer of epoxy-based photo-definable dry film disposed on a substrate, exposing the first layer to energy through a mask to form a pattern, defined by the mask, in the first layer of dry film, forming, from the exposed first layer of dry film, a polymer layer having a plurality of apertures extending therethrough, the plurality of apertures having a distribution defined by the pattern, and removing the polymer layer from the substrate. Unique filter holder designs and methods appropriate to hold microfilters to collect the rare cells and allow performing assays in the filter holder are provided. The invention also describes the use of the microfilter and filter holder to collect rare cells from body fluids and perform assays. Rare cells collected on the microfilter in accordance with embodiments of the present invention can be used for medical and biological research applications.


Patent
Creatv MicroTech Inc. | Date: 2014-03-13

A preservative reagent for urine is disclosed that increases the stability of cells, such as tumor cells, in urine for a period of several weeks. The preservative reagent comprises polyethylene glycol (PEG), ethanol, paraformaldehyde (PFA), and ethylenediaminetetraacetic acid (EDTA), and optionally pH stabilizing reagents.


Cytokeratin (CK)+/CD45/DAPI+ cells in the blood of cancer patients have been considered by most as circulating tumor cells (CTCs). Different methods of isolating CTCs results in a wide range of numbers and subgroups of CTCs from same patient. As a result, the clinical significance of the number of CTCs becomes cloudy. Provided herein is methodology to categorize CTCs into morphologically distinct subpopulations, and to use one of the subpopulations in methods for predicting overall survival of a patient having cancer.


Patent
Creatv MicroTech Inc. | Date: 2010-01-21

Micro- and nanofilters have a wide range of applications in many fields, including medical diagnostics, drug delivery, medical implants, and hemodialysis. Some issues that limit commercial application of current nanofilters in medicine are low pore density, non-uniform pore size, and the use of materials that are not biocompatible. A method is described to fabricate high porosity polymer and diamond micro- and nanofilters producing smooth, uniform and straight pores of high aspect ratio. Pore size, density, and shape can be predetermined with a high degree of precision by masks and controlled etch. The method combines energetic neutral atom beam lithography and a mask. This technology allows etching polymeric materials in a clean, well-controlled, and charge-free environment, making it very suitable for fabricating nanofilters and other components for biomedical applications.


A microfilter comprising a polymer layer formed from photo-definable dry film, and a plurality of apertures each extending through the polymer layer. A microfilter comprising two or more polymer layers formed from photo-definable dry film, and a plurality of apertures or open areas each extending through the polymer layer. Methods of forming apertures in one or more layers of photo-definable dry film are also disclosed. Filter holder designs and methods appropriate to hold microfilters to collect the rare cells and to perform of assays in the filter holder are provided. Microfiltration chip designs and methods appropriate to collect the rare cells and to perform assays in the microfluidic chips are provided. The invention also describes the use of the microfilter, filter holder and microfilter chips to collect rare cells from body fluids and perform assays, and these rare cells can be used for medical and biological research applications.

Loading Creatv MicroTech Inc. collaborators
Loading Creatv MicroTech Inc. collaborators